Registro de Cáncer de Girona

Descripción

El Registro de Cáncer de Girona (RCG) es un registro de base poblacional que recoge información sobre todos los casos de cáncer de la provincia de Girona desde el año 1994. Cubre una población aproximada de 747.157 habitantes (población a 1 de enero del año 2019 del Insituto de Estadística deCataluña, IDESCAT), residentes en las comarcas del Gironès, La Selva, Alt Empordà, Baix Empordà, Cerdanya, Garrotxa, Ripollès y Pla de l'Estany.

El RCG se creó  en 1994 como ampliación del Registro monográfico de cáncer de mama y genital femenino que estuvo en funcionamiento desde el año 1980 hasta el año 1989.  El encargado de llevarlo a cabo es la Unidad de epidemiología y registro del cáncer del Plan director de oncología.

El Registro es miembro de la Agencia Internacional de Registros de Cáncer (IACR) y sus datos se publican periódicamente en las monografías del Cancer Incidence in Five Continents, el último volumen se ha publicado durante el año 2007 y hace referencia a los datos del periodo 1998-2002.
También es miembro de la "Red europea de registros de cáncer" (ENCR). http://www.encr.com.fr/
Es también estadística oficial de Cataluña y su fichero está inscrito en la Agencia de Protección de datos.

Actividades

Dentro de los estudios epidemiológicos, las líneas de trabajo se centran en la epidemiología de las neoplasias hematológicas y los patrones de distribución geográfica de la incidencia de las neoplasias, conocer los factores de riesgo relacionados con el cáncer de mama y cáncer de cérvix, el riesgo de desarrollar cáncer y la curabilidad de las neoplasias evaluando la supervivencia relativa poblacional.

Publicaciones

  • Ameijide A, Clèries R, Carulla M, Buxó M, Marcos-Gragera R, Martínez JM, Vilardell ML, Vilardell M, Espinàs JA, Borràs JM, Izquierdo Á, Galceran J. Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona. Clin Transl Oncol. 2019 Jan 3. doi: 10.1007/s12094-018-02015-5. [Epub ahead of print]
  • Stradella A, Del Valle J, Rofes P, Feliubadaló L, Grau Garces È, Velasco À, González S, Vargas G, Izquierdo Á, Campos O, Tornero E, Navarro M, Balmaña-Gelpi J, Capellá G, Pineda M, Brunet J, Lázaro C. Does multilocus inherited neoplasia alleles syndrome have severe clinical expression? J Med Genet. 2018 Dec 22. pii: jmedgenet-2018-105700. doi: 10.1136/jmedgenet-2018-105700. [Epub ahead of print] PubMed PMID: 30580288.
  • Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Marcos-Gragera R, Vilardell ML, Carulla M, Espinàs JA, Galceran J, Borràs JM, Izquierdo Á. [Excess mortality among breast cancer patients in early stages in Tarragona and Gerona (Spain)]. Gac Sanit. 2018 Dec 17. pii: S0213-9111(18)30244-9. doi: 10.1016/j.gaceta.2018.09.008. [Epub ahead of print] Spanish.
  • Roca Barceló, G. Viñas, H. Pla, A. Carbó, R. Comas, Á. Izquierdo, P. S. Pinheiro, L. Vilardell, M. Solans, Marcos-Gragera R. Mortality of women with ductal carcinoma in situ of the breast: a population based study from the Girona province, Spain (1994–2013). Clinical and Translational Oncology. 2018 Des 10; doi.org/10.1007/s12094-018-1994-1
  • Casabonne D, Benavente Y, Costas L, Robles C, Gonzalez-Barca E, de la Banda E, Alonso E, Aymerich M, Campo E, Marcos-Gragera R, Tardón A, Olmedo-Requena R, Gimeno E, Martínez-López A, Casanovas O, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de Sanjosé S. Insulin-like growth factor levels and chronic lymphocytic leukaemia: results from the MCC-Spain and EpiLymph-Spain studies. Br J Haematol. 2018 Nov 19. doi: 10.1111/bjh.15583. [Epub ahead of print] No abstract available.
  • Solans M, Fàbrega A, Morea D, Auñon-Sanz C, Granada I, Roncero JM, Blanco A, Kelleher N, Buch J, Saez M, Marcos-Gragera R. Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain. Cancer Epidemiol. 2018 Nov 10;58:8-11. doi: 10.1016/j.canep.2018.11.001. [Epub ahead of print]
  • Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, Castro C, Rapiti E, Katalinic A, Torrella A, Žagar T, Bielska-Lasota M, Rossi PG, Larrañaga N, Bastos J, Sánchez MJ, Sant M; European HR Working Group on breast cancer. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 2018 Nov 8. doi: 10.1002/ijc.31974. [Epub ahead of print]
  • Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Arun BK, Ausems MGEM, Azzollini J, Barouk-Simonet E, Barwell J, Belotti M, Benitez J, Berger A, Borg A, Bradbury AR, Brunet J, Buys SS, Caldes T, Caligo MA, Campbell I, Caputo SM, Chiquette J, Claes KBM, Margriet Collée J, Couch FJ, Coupier I, Daly MB, Davidson R, Diez O, Domchek SM, Donaldson A, Dorfling CM, Eeles R, Feliubadaló L, Foretova L, Fowler J, Friedman E, Frost D, Ganz PA, Garber J, Garcia-Barberan V, Glendon G, Godwin AK, Gómez Garcia EB, Gronwald J, Hahnen E, Hamann U, Henderson A, Hendricks CB, Hopper JL, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Izquierdo Á, Jakubowska A, Kaczmarek K, Kang E, Karlan BY, Kets CM, Kim SW, Kim Z, Kwong A, Laitman Y, Lasset C, Hyuk Lee M, Won Lee J, Lee J, Lester J, Lesueur F, Loud JT, Lubinski J, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Miller A, Montagna M, Mooij TM, Morrison PJ, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Niederacher D, Nielsen FC, Nussbaum RL, Offit K, Olah E, Ong KR, Ottini L, Park SK, Peterlongo P, Pfeiler G, Phelan CM, Poppe B, Pradhan N, Radice P, Ramus SJ, Rantala J, Robson M, Rodriguez GC, Schmutzler RK, Hutten Selkirk CG, Shah PD, Simard J, Singer CF, Sokolowska J, Stoppa-Lyonnet D, Sutter C, Yen Tan Y, Teixeira RM, Teo SH, Terry MB, Thomassen M, Tischkowitz M, Toland AE, Tucker KM, Tung N, van Asperen CJ, van Engelen K, van Rensburg EJ, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Yannoukakos D; GEMO Study Collaborators; HEBON; EMBRACE, Greene MH, Rookus MA, Easton DF, Chenevix-Trench G, Antoniou AC, Goldgar DE, Olopade OI, Rebbeck TR, Huo D. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. J Natl Cancer Inst. 2018 Oct 12. doi: 10.1093/jnci/djy132. [Epub ahead of print] PubMed PMID: 30312457.
  • Gómez-Acebo I, Dierssen-Sotos T, de Pedro M, Pérez-Gómez B, Castaño-Vinyals G, Fernández-Villa T, Palazuelos-Calderón C, Amiano P, Etxeberria J, Benavente Y, Fernández-Tardón G, Salcedo-Bellido I, Capelo R, Peiró R, Marcos-Gragera R, Huerta JM, Tardón A, Barricarte A, Altzibar JM, Alonso-Molero J, Dávila-Batista V, Aragonés N, Pollán M, Kogevinas M, Llorca Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study. J. BMC Public Health. 2018 Sep 21;18(1):1134. doi: 10.1186/s12889-018-6019-z.
  • Solans M, Coenders G, Marcos-Gragera R, Castelló A, Gràcia-Lavedan E, Benavente Y, Moreno V, Pérez-Gómez B, Amiano P, Fernández-Villa T, Guevara M, Gómez-Acebo I, Fernández-Tardón G, Vanaclocha-Espi M, Chirlaque MD, Capelo R, Barrios R, Aragonés N, Molinuevo A, Vitelli-Storelli F, Castilla J, Dierssen-Sotos T, Castaño-Vinyals G, Kogevinas M, Pollán M, Saez M. Compositional analysis of dietary patterns. Stat Methods Med Res. 2018 Jul 26:962280218790110. doi: 10.1177/0962280218790110. [Epub ahead of print]
  • Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M; MCC-Spain Study Group. [Corrigendum a: Estudio multicaso-control de base poblacional de tumores comunes en España (MCC-Spain): razón y diseño del estudio (Gaceta Sanitaria 2015;29:308-15)] Gac Sanit. 2018 Sep - Oct;32(5):501. doi: 10.1016/j.gaceta.2018.04.004. Epub 2018 Jul 20. Spanish. No abstract available.
  • Kogevinas M, Espinosa A, Castelló A, Gómez-Acebo I, Guevara M, Martin V, Amiano P, Alguacil J, Peiro R, Moreno V, Costas L, Fernández-Tardón G, Jimenez JJ, Marcos-Gragera R, Perez-Gomez B, Llorca J, Moreno-Iribas C, Fernández-Villa T, Oribe M, Aragones N, Papantoniou K, Pollán M, Castano-Vinyals G, Romaguera D. Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study). Int J Cancer. 2018 Jul 17. doi: 10.1002/ijc.31649. [Epub ahead of print].
  • Solans M; Castelló A; Benavente Y; Marcos-Gragera R; Amiano P; Gracia-Lavedan E; Costas L; Robles C; Gonzalez Barca E; de la Banda E; Alonso E; Aymerich M; Campo E; Dierssen-Sotos T; Fernández-Tardón G; Olmedo-Requena R; Gimeno E; Castaño-Vinyals G; Aragonés N; Kogevinas M; de Sanjose S; Pollán M; Casabonne D. Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study. Haematologica. 2018 Jun 28. pii: haematol.2018.192526. doi: 10.3324/haematol.2018.192526.
  • Rubió-Casadevall J, Puig-Vives M, Puigdemont M, Vilardell L, Carbó-Bagué A, Marcos-Gragera R, Vilar-Coromina N. Patterns of increased incidence and survival of cutaneous melanoma in Girona (Spain) 1994-2013: a population-based study. Clin Transl Oncol. 2018 Jun 5. doi: 10.1007/s12094-018-1900-x. [Epub ahead of print]
  • Torras MG, Canals E, Jurado-Bruggeman D et al. Clinical Audit of the Radiotherapy Process in Rectal Cancer: Clinical Practice Guidelines and Quality Certification Do Not Avert Variability in Clinical Practice. Transl Oncol 2018 June 2018; 11: 794-9.
  • Fuentes-Raspall R, Solans M, Auñon-Sanz C, Saez M, Marcos-Gragera R.  Incidence and survival of primary central nervous system lymphoma (PCNSL): results from the Girona cancer registry (1994-2013). Clin Transl Oncol. 2018 May 23. doi: 10.1007/s12094-018-1890-8. [Epub ahead of print] No abstract available.
  • Clèries R, Ameijide A, Marcos-Gragera R, Pareja L, Carulla M, Vilardell ML, Esteban L, Buxó M, Espinàs JA, Puigdefàbregas A, Ribes J, Izquierdo A, Galceran J, Borrás JM. Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly. Clin Transl Oncol. 2018 May;20(5):647-657. doi: 10.1007/s12094-017-1764-5. Epub 2017 Oct 12.
  • Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EI, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomäki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmaña J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo SM, Chiquette J, Chung WK, Claes KBM, Collée JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C, Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B; EMBRACE, Engel C, Engert S, Evans DG, Faivre L, Feliubadaló L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvão HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A; GEMO Study Collaborators, Gerdes AM, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J; HEBON, Henderson A, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Vijai J, Kaczmarek K, Karlan BY, Kast K, Investigators K, Kim SW, Konstantopoulou I, Korach J, Laitman  Y, Lasa A, Lasset C, Lázaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martínez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky  J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Öfverholm A, Ong KR, Osorio A, Papi L, Papp J,  Pasini B, Pedersen IS, Peixoto A, Peruga N, Peterlongo P, Pohl E, Pradhan N, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte AB, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G, Sutter C, Szabo CI, Tan YY, Teixeira MR, Terry MB, Teulé A, Thomas A, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Topka S, Trainer AH, Tung N, van Asperen CJ, van der Hout AH, van der Kolk LE, van der Luijt RB, Van Heetvelde M, Varesco L, Varon-Mateeva R, Vega A, Villarreal-Garza C, von Wachenfeldt A, Walker L, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Yoon SY, Zanzottera C, Zidan J, Zorn KK, Hutten Selkirk CG, Hulick PJ, Chenevix-Trench G, Spurdle AB, Antoniou AC, Nathanson KL. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12. PubMed PMID: 29446198; PubMed Central PMCID: PMC5903938.
  • Botta L, Capocaccia R, Trama A, Herrmann C, Salmerón D, De Angelis R, Mallone S, Bidoli E, Marcos-Gragera R, Dudek-Godeau D, Gatta G, Cleries R; RACECAREnet Working group. Bayesian estimates of the incidence of rare cancers in Europe. Cancer Epidemiol. 2018 Apr 20;54:95-100. doi: 10.1016/j.canep.2018.04.003. [Epub ahead of print]. PMID: 29684802
  • Lope V, Castelló A, Mena-Bravo A, Amiano P, Aragonés N, Fernández-Villa T, Guevara M, Dierssen-Sotos T, Fernandez-Tardón G, Castaño-Vinyals G, Marcos-Gragera R, Moreno V, Salas-Trejo D, Diaz-Santos M, Oribe M, Romieu I, Kogevinas M, Priego-Capote F, Pérez-Gómez B, Pollán M. Serum 25-Hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain). J. Steroid Biochem Mol Biol. 2018 Apr 18. pii: S0960-0760(18)30132-8. doi: 10.1016/j.jsbmb.2018.04.005. [Epub ahead of print] PMID:     29679754.
  • Marcos-Gragera R, Solans M, Galceran J, Fernández-Delgado R, Fernández-Teijeiro A, Mateos A, Quirós-Garcia JR, Fuster-Camarena N, De Castro V, Sánchez MJ, Franch P, Chirlaque MD, Ardanaz E, Martos C, Salmerón D, Peris-Bonet R; Spanish Childhood Cancer Epidemiology Working Group (Marcos-Gragera R, Vilardell L). Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clin Transl Oncol. 2018 Apr 5.
  • García-Pérez J, Lop V, Pérez-Gómez B, Molina AJ, Tardón A, Díaz Santos MA, Ardanaz E, O'Callaghan-Gordo C, Altzibar JM, Gómez-Acebo I, Moreno V, Peiró R, Marcos-Gragera R, Kogevinas M, Aragonés N, López-Abente G, Pollán M. Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain). Environ Pollut. 2018 Mar 7;237:559-568.
  • Clèries R, Ameijide A, Buxó M, Martínez JM, Marcos-Gragera R, Vilardell ML, Carulla M, Yasui Y, Vilardell M, Espinàs JA, Borràs JM, Galceran J, Izquierdo À. Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004). Clin Transl Oncol. 2018 Mar 6.
  • Minicozzi P, Walsh PM, Sánchez MJ, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannesen TB, Rossi S, Sant M; EUROCARE-5 Working Group  (Marcos-Gragera R; Vilardell ML and Izquierdo A). Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis? Eur J Cancer. 2018 Mar 5;93:127-137.
  • Solans M, Osca-Gelis G, Comas R, Roncero JM, Gallardo D, Marcos-Gragera R, Saez M. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain. Cancer Causes & Control. 2018 Mar;29(3):379-382.
  • Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Fernández-Navarro P, Altzibar JM, González-Donquiles C, Ardanaz E, Bustamante M, Alonso-Molero J, Vidal C, Bayo-Calero J, Tardón A, Salas D, Marcos-Gragera R, Moreno V, Rodriguez-Cundin P, Vinyals GC, Ederra M, Vilorio-Marqués L, Amiano P, Pérez-Gómez B, Aragonés N, Kogevinas M, Pollán M, Llorca J. Validating a breast cancer score in Spanish women. The MCC-Spain study. Sci Rep. 2018 Feb 14;8(1):3036.
  • Benavente Y, Casabonne D, Costas L, Robles C, Alonso E, de la Banda E, Gonzalez-Barca E, Marcos-Gragera R, Llorca J, Tardón A, Monleon JJ, Aymerich M, Campo E, Gimeno-Vázquez E, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de Sanjosé S. Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study. Cancer Epidemiol. 2018 Feb;52:106-111.
  • Chirlaque MD, Salmerón D, Galceran J, Ameijide A, Mateos A, Torrella A, Jiménez R, Larrañaga N, Marcos-Gragera R, Ardanaz E, Sant M, Minicozzi P, Navarro C, Sánchez MJ; REDECAN Working Group (Marcos-Gragera R, Izquierdo A, Vilardell ML). Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2018 Feb;20(2):201-211.
  • Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM. WebSurvCa: Web-based estimation of death and survival probabilities in a cohort]. Gac Sanit. 2018 Jan 19. pii: S0213-9111(17)30306-0.
  • Steliarova-Foucher E, Fidler MM, Colombet M, Lacour B, Kaatsch P, Piñeros M, Soerjomataram I, Bray F, Coebergh JW, Peris-Bonet R, Stiller CA; ACCIS contributors   (Marcos-Gragera R).  Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991-2010 (Automated Childhood Cancer Information System): a population-based study. Lancet Oncol. 2018 Aug 8. pii: S1470-2045(18)30423-6. doi: 10.1016/S1470-2045(18)30423-6. [Epub ahead of print].
  • Orlandi E, Alfieri S, Simon C, Trama A, Licitra L, RARECAREnet Working Group (Marcos-Gragera R). Treatment challenges in and outside a network setting: Head and neck cancers. Eur J surg Oncol. 2018 Feb 14. pii: S0748-7983(18)30417-7.
  • Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group. RARECAREnet Working Group (Marcos-Gragera R). Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol. 2018 Feb 14. pii: S0748-7983(18)30416-5.
  • Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group (Marcos-Gragera R).  Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30114-8.
  • Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group (Marcos-Gragera R, Vilardell Gil ML). Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018 Jan 30. pii: S0140-6736(17)33326-3.
  • Benavente Y, Casabonne D, Costas L, Robles C, Alonso E, de la Banda E, González-Barca E, Marcos-Gragera R, Llorca J, Tardón A, Monleon JJ, Aymerich M, Campo E, Gimeno-Vázquez E, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, de San José S. Established and suggested exposures on CLL/SLL etiology: Results from the CLL-MCC-Spain study. Cancer Epidemiol. 2017 Dec 28;52:106-111.
  • Clèries R; Ameijide A; Marcos-Gragera R; Pareja L; Carulla M; Vilardell ML; Esteban L; Buxó M; Espinàs JA; Puigdefàbregas A; Ribes J; Izquierdo A; Galceran J; Borràs JM. Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly. Clin Transl Oncol. 2017 Oct 12. doi: 10.1007/s12094-017-1764-5. [Epub ahead of print].
  • Pamela Minicozzi; Kaire Innos; María-José Sánchez; Annalisa Trama; Paul M Walsh; Rafael Marcos-Gragera, Nadya Dimitrova, Laura Botta, Otto Visser, Silvia Rossi, Andrea Tabilla, Milena Sant, The EUROCARE-5 Working Group. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer. 2017 Aug 30;84:335-353.
  • Rafael Fuentes-Raspall; Marta Solans; Aina Roca-Barceló; Loreto Vilardell; Montse Puigdemont; Sonia del Barco; Raquel Comas; Adelaida García-Velasco; Aurora Astudillo; MC Carmona-García; and  Rafael Marcos-Gragera. Population-based incidence, trends and survival of primary malignant and non-malignant central nervous system tumors in Spain: results from the Girona Registry (1994-2013). Cancer Epidemiol. 2017 Jul 21;50(Pt A):1-8. doi: 10.1016/j.canep.2017.07.005.
  • Marta Solans; Laura Serra; Gemma Renart; Gemma Osca-Gelis; Raquel Comas; Loreto Vilardell; Joan Buch; David Gallardo; Rafael Marcos-Gragera. Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study. Eur J Cancer Prev. 2017 Jun 5.
  • Pinheiro PS; Callahan KE; Gomez SL; Marcos-Gragera R; Cobb TR; Roca-Barceló A; Ramirez AG. High cancer mortality for US-born Latinos: evidence from California and Texas. BMC Cancer. 2017 Jul 11;17(1):478. doi: 10.1186/s12885-017-3469-0.
  • Chirlaque MD; Salmerón D; Galceran J; Ameijide A; Mateos A; Torrella A; Jiménez R; Larrañaga N; Marcos-Gragera R; Ardanaz E; Sant M; Minicozzi P; Navarro C; Sánchez MJ; REDECAN Working Group. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2017 Jul 17.
  • Gemma Gatta; Rafael Peris Bonet; Otto Visser; Charles Stiller; Rafael Marcos-Gragera; Maria Jose Sanchez; Laura Botta; the EUROCARE-5 Working Group. Geographical variation in European children with Central Nervous System tumors. Eur J Cancer. 2017 Sep;82:137-148. doi: 10.1016/j.ejca.2017.05.028. Epub 2017 Jul 6.
  • Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; Spika D; Marcos-Gragera R; Peris-Bonet R; Piñeros M; Sant M; Kuehni CE; Murphy MFG; Coleman MP; Allemani C; CONCORD Working Group. Worldwide comparison of survival from childhood leukemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol 2017 May;4(5):e202-e217.
  • Romaguera D; Gracia-Lavedan E; Molinuevo A; de Batlle J; Méndez M; Moreno V; Vidal C; Castelló A; Pérez-Gómez B; Martín V; Molina AJ; Dávila-Batista V; Dierssen-Sotos T; Gómez-Acebo I; Llorca J; Guevara M; Castilla J; Urtiaga C; Llorens-Ivorra C; Fernández-Tardón G; Tardón A; Lorca JA; Marcos-Gragera R; Huerta JM; Olmedo-Requena R; Jiménez-Moleón JJ; Altzibar J; de San José S; Pollán M; Aragonés N; Castaño-Vinyals G; Kogevinas M; Amiano P. Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study. Int J Cancer. 2017 Jul 1;141(1):83-93.
  • Marcos-Gragera R; Galceran J; Martos C; de Munain AL; Vicente-Raneda M; Navarro C; Quirós-García JR; Sánchez MJ; Ardanaz E; Ramos M; Mateos A; Salmerón D; Felipe S; Peris-Bonet R. Incidence and survival time trends for Spanish children and adolescents with leukemia from 1983 to 2007. Clin Transl Oncol 2017 Mar;19(3):301-316.
  • Annalisa Trama; Rafael Marcos-Gragera; María José Sánchez Pérez; Jan-Maarten van der Zwan; Eva Ardanaz; Christine Bouchardy; Juan Manuel Melchor; Carmen Martínez; Riccardo Capocaccia; Massimo Vicentini; Sabine Siesling; Gemma Gatta  and the RARECARE working group contributing to the data quality study. Data quality in rare cancers registration: the report of the RARECARE data quality study. Tumor. 2017 Jan 21;103(1):22-32.
  • Mangone L, Bossard N, Marcos-Gragera R, Pezzarossi A, Roncaglia F, Giorgi Rossi P; GRELL EUROCARE-5 Working Group. Trends in net survival from kidney cancer in six European Latin countries: results from the SUDCAN population-based study. European Journal of Cancer Prevention: January 2017 - Volume 26 - Issue - p S121–S127.
  • Galceran J; Uhry Z; Marcos-Gragera R; Borràs J; GRELL EUROCARE-5 Working Group. Trends in net survival from skin malignant melanoma in six European Latin countries: results from the SUDCAN population-based study. European Journal of Cancer Prevention: January 2017 - Volume 26 - Issue - p S77–S84.
  • Lepage, Côme; Bossard, Nadine; Dejardin, Olivier; Carmona-Garcia, Maria C.; Manfredi, Sylvain; Favre, Jean; GRELL EUROCARE-5 Working Group. Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-base study. European Journal of Cancer Prevention: January 2017 - volume-26- Issue- pS48-S55. ISSN 0959-8278.
  • Galceran J; Ameijide A; Carulla M; Mateos A; Quirós JR; Rojas D; Alemán A; Torrella A; Chico M; Vicente M; Díaz JM; Larrañaga N; Marcos-Gragera R; Sánchez MJ; Perucha J; Franch P; Navarro C; Ardanaz E; Bigorra J; Rodrigo P; Bonet RP; REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jan 16. doi: 10.1007/s12094-016-1607-9.
  • Casabonne D, Gracia E, Espinosa A, Bustamante M, Benavente Y, Robles C, Costas L, Alonso E, González-Barca E, Tardón A, Dierssen-Sotos T, Vázquez EG, Aymerich M, Campo E, Jiménez-Moleón JJ, Marcos-Gragera R, Castaño-Vinyals G, Aragonés N, Pollán M, Kogevinas M, Urtiaga C, Amiano P, Moreno V, de Sanjosé S. Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukemia. Eur J Nutr. 2017 Apr;56(3):1123-1133.
  • Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A; RARECARE net working group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Burden and centralized treatment in Europe of rare tumors: results of RARECARE net a population-based study. Lancet Oncol. 2017 Jul 4. pii: S1470-2045(17)30445-X.
  • Gatta G, Trama A, Capocaccia R; RARECARE Net Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30685-6. doi: 10.1016/j.ejso.2017.08.018. [Epub ahead of print]
  • Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARE Net Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2017 Sep 19. pii: S0748-7983(17)30705-9. doi: 10.1016/j.ejso.2017.09.015.
  • Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARE Net Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R)Treatment challenges in and outside a specialist network setting: Pancreatic  neuroendocrine tumors. Eur J Surg Oncol. 2017 Oct 16. pii: S0748-7983(17)30941-1. doi: 10.1016/j.ejso.2017.08.019. [Epub ahead of print].
  • Ray-Coquard I; Trama A; Seckl MJ; Fotopoulou C; Pautier P; Pignata S; Kristensen G; Mangili G; Falconer H; Massuger L; Sehouli J; Pujade-Laurine E; Lorusso D; Amant F; Rokkones E; Vergote I; Ledermann JA; RARECARE Net Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Rare ovarian tumors: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. 2017 Nov 3. pii: S0748-7983(17)30947-2.
  • Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD 2. Working Group (Loreto Vilardell; Marcos-Gragera R). Gynecol Oncol. 2017 Jul 5.
  • Steliarova-Foucher E; Colomet M; Ries LAG; Moreno F4; Dolya A; Bray F; Hesseling P; Shin HY; Stiller CA; IICC-3 contributors (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. 2017 Apr 11. pii: S1470-2045(17)30186-9. doi: 10.1016/S1470-2045(17)30186-9. [Epub ahead of print] .
  • Dal Maso L; Tavilla A; Pacini F; Serraino D; van Dijk BAC; Chirlaque MD; Capocaccia R; Larrañaga N; Colonna M; Agius D; Ardanaz E; Rubió-Casadevall J; Kowalska A; Virdone S; Mallone S; Amash H; De Angelis R; EUROCARE-5 Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017 Apr 11;77:140-152. doi: 10.1016/j.ejca.2017.02.023. [Epub ahead of print] 
  • Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, Capocaccia R, Larrañaga N, Colonna M, Agius D, Ardanaz E, Rubió-Casadevall J, Kowalska A, Virdone S, Mallone S, Amash H, De Angelis R; EUROCARE-5 Working Group (Angel Izquierdo, Loreto Vilardell, Marcos-Gragera R). Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. 2017 May;77:140-152. doi: 10.1016/j.ejca.2017.02.023. Epub 2017 Apr 11.
  • Clèries R; Ameijide A; Buxó M; Vilardell M; Martínez JM; Alarcón F; Cordero D; Díez-Villanueva, Yasui Y; Marcos-Gragera R; Vilardell ML; Carulla M; Galceran J; Izquierdo A; Moreno V; Borràs JM. WebSurvCa: estimación vía web de las probabilidades de fallecimiento y de supervivencia de una cohorte. Gac Sanit. 2017
  • Josep Maria Borràs; Angel Izquierdo; Loreto Vilardell; Rafael Marcos-Gragera; Josepa Ribes; Jordi Gálvez; Laura Esteban (2017). Cancer Incidence in Girona (2008-2012). In: Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R and Ferlay J, editors Cancer Incidence in Five Continents, Vol. XI (electronic version). Lyon: International Agency for Research on Cancer. Available from: http://ci5.iarc.fr, accessed [16 de gener de 2018].
  • Annalisa Trama; Rafael Marcos-Gragera; María José Sánchez Pérez; Jan-Maarten van der Zwan; Eva Ardanaz; Christine Bouchardy; Juan Manuel Melchor; Carmen Martinez; Riccardo Capocaccia; Massimo Vicentini; Sabine Siesling; Gemma Gatta  and the RARECARE working group contributing to the data quality study. Data quality in rare cancers registration: the report of the RARECARE data quality study. Tumori 2016 Oct 3
  • Ramon Clèries; Maria Buxó; Yutaka Yasui; Rafael Marcos-Gragera; José M. Martínez; Alberto Ameijide; Jaume Galceran; Josep M. Borràs; Àngel Izquierdo. Long-Term crude probability of death due to breast cancer and other causes among young breast cancer patients: a Bayesian approach. Tumori 2016 Dec 1;102(6):555-561
  • Rubió-Casadevall J; Hernandez-Pujol AM; Ferreira-Santos MC; Morey-Esteve G; Vilardell L; Osca-Gelis G; Vilar-Coromina N; Marcos-Gragera R.Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain : a population based study. Cancer Epidemiology 2016 Sep 14;45:6-10.
  • Trinidad Dierssen-Sotos; Ines Gomez-Acebo; Maria de Pedro; Beatriz Perez-Gomez; Sonia Servitja; Victor Moreno; Pilar Amiano; Tania Fernandez-Villa; Aurelio Barricarte; Adonina Tardon; Marian Diaz-Santos; Rosana Peiro-Perez; Rafael Marcos-Gragera; Virginia Lope; Esther Gracia-Lavedan; M. Henar Alonso; Maria Jesus Michelena-echeveste; Andres Garcia-Palomo; Marcela Guevara; Gemma Castano-Vinyals; Nuria Aragones; Manolis Kogevinas; Marina Pollan; Javier LLorca.  Use of non-steroidal anti-inflammatory drugs and risk of breast cancer. The Spanish Multi-Case-Control (MCC) Study. BMC Cancer. 2016 Aug 20;16(1):660.
  • Marcos-Gragera R; Galceran J; Martos C; de Munain AL; Vicente-Raneda M; Navarro C; Quirós-Garcia JR; Sánchez MJ; Ardanaz E; Ramos M; Mateos A; Salmerón D; Felipe S; Peris-Bonet R. Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007. Clin Transl Oncol. 2016 Jul 22.
  • Ines Gomez-Acebo; Trinidad Dierssen-Sotos; Camilo Palazuelos; Beatriz Pérez-Gómez; Virginia Lope; Ignasi Tusquets; M. Henar Alonso; Victor Moreno; Pilar Amiano; Antonio José Molina de la Torre; Aurelio Barricarte; Adonina Tardon; Antonio Camacho; Rosana Peiro-Perez; Rafael Marcos-Gragera; Montse Muñoz; Maria Jesus Michelena-Echeveste; Luis Ortega Valin; Marcela Guevara; Gemma Castaño-Vinyals; Nuria Aragonés; Manolis Kogevinas; Marina Pollán; Javier Llorca. The use of antihypertensive medication and the risk of breast cancer in a case-control study in a Spanish population: the MCC-Spain study. PLoS One. 2016 Aug 10;11(8):e0159672
  • Laura Costas; Yolanda Benavente; Rocío Olmedo-Requena; Delphine Casabonne; Claudia Robles; Eva-Maria Gonzalez-Barca; Esmeralda de la Banda; Esther Alonso; Marta Aymerich; Adonina Tardón; Rafael Marcos-Gragera; Eva Gimeno-Vázquez; Inés Gómez-Acebo; Kyriaki Papantoniou; Gemma Castaño-Vinyals; Nuria Aragonés; Marina Pollán; Manolis Kogevinas; Silvia de Sanjosé. Night Shift Work and Chronic Lymphocytic Leukemia in the MCC-Spain case-control study. Int J Cancer. 2016 Nov 1;139(9):1994-2000.
  • Abrahão R; Keogh RH; Lichtensztajn DY; Marcos-Gragera R; Medeiros BC; Coleman MP; Ribeiro RC; Keegan TH. Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988-2011: a population-based study. Br J Haematol. 2016 Apr;173(2):292-302.
  • Tejera-Vaquerizo A; Descalzo-Gallego MA; Otero-Rivas MM; Posada-García C; Rodríguez-Pazos L; Pastushenko I; Marcos-Gragera R; García-Doval I. Skin Cancer Incidence and Mortality in Spain: A Systematic Review and Meta-Analysis. Actas Dermosifiliogr. 2016 May;107(4):318-328.
  • Nerea Larranaga; Ma Jose Sanchez; Eva Ardanaz; Saray Felipe; Rafael Marcos-Gragera; Maria Ramos; Marià Carulla; Ma Dolores Chirlaque; Marcial V. Arguelles; Carmen Martos; Antonio Mateo and Rafael Peris-Bonet. Incidence Patterns and Trends of non-Central Nervous System Solid Tumours in Children and Adolescents. A Collaborative Study of the Spanish Population Based Cancer Registries. J Cancer 2016; 7(3):335-343. doi:10.7150/jca.12943.
  • García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M. Association of diabetes and diabetes treatment with incidence of breast cancer. Acta Diabetol. 2016 Feb;53(1):99-107.
  • Lope V; García-Esquinas E; Pérez-Gómez B; Altzibar JM; Gracia-Lavedan E; Ederra M; Molina de la Torre AJ; LLorca FJ; Tardón A; Moreno V; Bayo J; Salas-Trejo D; Marcos-Gragera R; Pumarega J; Dierssen-Sotos T; Lera JP; de Miguel Medina MA; Tusquets I; Amiano P; Boldo E; Kogevinas M; Aragonés N; Castaño-Vinyals G; Pollán M. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood. Cancer Epidemiol 2016;40:22-30
  • Casabonne D, Gracia E, Espinosa A, Bustamante M, Benavente Y, Robles C, Costas L, Alonso E, Gonzalez-Barca E, Tardón A, Dierssen-Sotos T, Vázquez EG, Aymerich M, Campo E, Jiménez-Moleón JJ, Marcos-Gragera R, Castaño-Vinyals G, Aragones N, Pollan M, Kogevinas M, Urtiaga C, Amiano P, Moreno V, de Sanjose S. Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia. Eur J Nutr. 2016 Feb 2.
  • Hofvind S, Holen Å, Román M, Sebuødegård S, Puig-Vives M, Akslen L. Mode of detection:an independent prognostic factor for women with breast cancer. J Med Screen. 2016 Jun;23(2):89-97.
  • Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, Caligo MA, Campbell I, Chan SB, Claes KB, Cohn DE, Cook J, Daly MB, Damiola F, Davidson R, Pauw Ad, Delnatte C, Diez O, Domchek SM, Dumont M, Durda K, Dworniczak B, Easton DF, Eccles D, Edwinsdotter Ardnor C, Eeles R, Ejlertsen B, Ellis S, Evans DG, Feliubadalo L, Fostira F, Foulkes WD, Friedman E, Frost D, Gaddam P, Ganz PA, Garber J, Garcia-Barberan V, Gauthier-Villars M, Gehrig A, Gerdes AM, Giraud S, Godwin AK, Goldgar DE, Hake CR, Hansen TV, Healey S, Hodgson S, Hogervorst FB, Houdayer C, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, et Al. Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS One. 2016 Jul 27;11(7):e0158801. doi: 10.1371/journal.pone.0158801. PubMed PMID: 27463617; PubMed Central PMCID: PMC4963094.
  • Madorsky-Feldman D, Sklair-Levy M, Perri T, Laitman Y, Paluch-Shimon S, Schmutzler R, Rhiem K, Lester J, Karlan BY, Singer CF, Van Maerken T, Claes K, Brunet J, Izquierdo A, Et Al. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2016 Jun;157(2):319-27. doi: 10.1007/s10549-016-3805-0. PubMed PMID: 27117159.
  • Quiles F, Teulé À, Martinussen Tandstad N, Feliubadaló L, Tornero E, Del Valle J, Menéndez M, Salinas M, Wethe Rognlien V, Velasco A, Izquierdo A, Capellá G, Brunet J, Lázaro C. Identification of a founder BRCA1 mutation in the Moroccan population. Clin Genet. 2016 Oct;90(4):361-5. doi: 10.1111/cge.12747. PubMed PMID: 26864382.
  • Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators., Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Et Al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y. PubMed PMID: 26857456; PubMed Central PMCID: PMC4746828.
  • Quiles F, Menéndez M, Tornero E, del Valle J, Teulé À, Palanca S, Izquierdo A, Gómez C, Campos O, Santamaria R, Brunet J, Capellá G, Feliubadaló L, Lázaro C. Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA. Breast Cancer Res Treat. 2016 Jan;155(2):253-60. doi: 10.1007/s10549-015-3676-9. PubMed PMID: 26780556.
  • Lope V; García-Esquinas E; Pérez-Gómez B; Altzibar JM; Gracia-Lavedan E; Ederra M; Molina de la Torre AJ; LLorca FJ; Tardón A; Moreno V; Bayo J; Salas-Trejo D; Marcos-Gragera R; Pumarega J; Dierssen-Sotos T; Lera JP; de Miguel Medina MA; Tusquets I; Amiano P; Boldo E; Kogevinas M; Aragonés N; Castaño-Vinyals G; Pollán M. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood. Cancer Epidemiol. 2015 Nov 21;40:22-30.
  • De Angelis R; Minicozzi P; Sant M; Dal Maso L; H. Brewster D; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A the EUROCARE-5 Working Group, Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study. European Journal of Cancer 2015,51: 2254-2268.
  • Marcos-Gragera R; Mallone S; A. Kiemeney L; Vilardell L; Malats N; Allory Y; Sant M; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer 2015,51: 2217-2230.
  • Baili P; Di Salvo F; Marcos-Gragera R; Siesling S; Mallone S; Santaquilani M; Micheli A; Lillini R; Francisci S; EUROCARE-5 Working Group. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. European Journal of Cancer 2015,51: 2120-2129
  • Kyriaki Papantoniou; Gemma Castaño-Vinyals; Ana Espinosa; Nuria Aragonés; Beatriz Pérez-Gómez; Eva Ardanaz; Jone M Altzibar; Vicente Martin Sanchez; Inés Gómez-Acebo; Javier Llorca; David Muñoz; Adonina Tardón; Rosana Peiró; Rafael Marcos-Gragera; Marina Pollan; Manolis Kogevinas.Breast cancer risk and night shift work in a case-control study in a Spanish population. Eur J Epidemiol. 2015 Jul 24.
  • Renata Abrahão; Daphne Y. Lichtensztajn; Raul C. Ribeiro; Neyssa M. Marina; Ruth Keogh, Rafael Marcos-Gragera;  Sally L. Glaser and Theresa H.M. Keegan. Racial/ethnic and socioeconomic disparities in survival among children with acute lymphoblastic leukemia in California, 1988–2011: a population-based observational study. Pediatr Blood Cancer. 2015 Oct;62(10):1819-25. doi: 10.1002/pbc.25544. Epub 2015 Apr 20.
  • Costas L; Sequera VG; Quesada P; Altzibar JM; Lope V; Pérez-Gómez B; Benavente Y; Martín V; Casabonne D; Robles C; Llorca J; Moreno-Iribas C; Fernandez-Tardón G; Moreno V; Caballero-Granado FJ; Salas D; Jiménez-Moleón JJ; Marcos-Gragera R; Chirlaque MD; Amiano P; Molina AJ; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; de Sanjosé S. Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use. Menopause. 2015 Oct;22(10):1138-46.
  • Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo E Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; the CONCORD Working Group.Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,877 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet  2015; 385(9972):977-1010.
  • Gemma Castaño-Vinyals,  Nuria Aragonés, Beatriz Pérez-Gómez, Vicente Martín, Javier Llorca, Victor Moreno, Jone M. Altzibar, Eva Ardanaz, Sílvia de Sanjosé, José Juan Jiménez-Moleón, Adonina Tardón, Juan Alguacil, Rosana Peiró, Rafael Marcos-Gragera, Carmen Navarro, Marina Pollán, Manolis Kogevinas, MCC-Spain Study Group. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design. Gac Sanit 2015;29(4):308-15.
  • Jordi Rubió-Casadevall, Joan Lluis Borràs, Maria Carme Carmona-García, Alberto Ameijide, Allan Gonzalez-Vidal, Maria Rosa Ortiz, Ramon Bosch, Francesc Riu, David Parada, Esther Martí, Josefina Miró, Juan Jose Sirvent, Jaume Galceran and Rafael Marcos-Gragera. Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study. World Journal of Surgical Oncology 2015, 13:47.
  • Anna Gavin; Brian Rous;  Rafael Marcos-Gragera; Richard Middleton; Eva Steliarova-Foucher; Marc Maynadie; Roberto Zanetti; Otto Visser. Towards optimal clinical and epidemiological registration of Haematological Malignancies: guidelines for recording progressions, transformations and multiple diagnoses. Eur J Cancer. 2015 Jun;51(9):1109-22.
  • Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R. Is survival in myeloid malignancies really improving? A retrospective 15 year population-based study.Leuk Lymphoma. 2015 Apr;56(4):896-902.
  • Rossi S; Baili P; Capocaccia R; Caldora M; Carrani E; Minicozzi P; Pierannunzio D; Santaquilani M; Trama A; Allemani A; Belot A; Buzzoni C; Lorez M; De Angelis R and EUROCARE-5 Working Group (Marcos-Gragera R & Vilardell L (Girona Cancer Registry)). The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods. European Journal of Cancer 2015,51: 2104-2119.
  • Baili P; Di Salvo F; Marcos-Gragera R; Siesling S; Mallone S; Santaquilani M; Micheli A; Lillini R; Francisci S and the EUROCARE-5 Working Group (Marcos-Gragera R & Vilardell L (Girona Cancer Registry)). Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study,. European Journal of Cancer 2015,51: 2120-2129.
  • Gatta G; Botta L; Sánchez MJ; Anderson LA; Pierannunzio D; Licitra L and EUROCARE Working Group (Marcos-Gragera R & Vilardell L (Girona Cancer Registry)). Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. European Journal of Cancer 2015;51:2130-2143.
  • Anderson LA; Tavilla A; Brenner H; Luttmann S; Navarro C; Gavin AT; Holleczek B; Johnston BT; Cook MB; Bannon F; Sant M and EUROCARE-5 Working Group (Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5, European Journal of Cancer 2015;51:2144-2157.
  • Holleczek B; Rossi S; Agius D; Innos K; Minicozzi P; Francisci S; Hackl M; Eisemann N; Brenner H and EUROCARE-5 Working Group (Marcos-Gragera R & Vilardell L (Girona Cancer Registry)). On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study.European Journal of Cancer 2015,51: 2158-2168.
  • Lepage C; Capocaccia R; Hackl M; Lemmens V; Molina E; Pierannunzio D; Sant M; Trama A; Faivre J and EUROCARE-5 Working Group (Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)).Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5. European Journal of Cancer 2015,51:2169-2178.
  • Crocetti E; Mallone S; Robsahm T.E; Gavin A; Agius D; Ardanaz E; Chirlaque Lopez M.D; Innos K; Minicozzi M; Borgognoni L; Pierannunzio D; Eisemann N and EUROCARE-5 Working Group (Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study, European Journal of Cancer 2015,51:2179-2190
  • Sant M; Chirlaque Lopez M.D; Agresti R; Sánchez Pérez M.J; Holleczek B; Bielska-Lasota M; Dimitrova N; Innos K; Katalinic A; Langseth H; Larrañaga N; Rossi S; Siesling S; Minicozzi P and The EUROCARE-5 Working Group(Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study, European Journal of Cancer 2015,51: 2191-2205.
  • Trama A; Foschi R; Larrañaga N; Sant M; Fuentes-Raspall R; Serraino D; Tavilla A; Van Eycken L; Nicolai N AND EUROCARE-5 Working Group (Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study. European Journal of Cancer 2015,51: 2206-2216.
  • Marcos-Gragera R; Mallone S; A. Kiemeney L; Vilardell L; Malats N; Allory Y; Sant M; EUROCARE-5 Working Group (Marcos-Gragera R & Vilardell L (Girona Cancer Registry)). Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer 2015,51: 2217-2230.
  • Visser O; Ardanaz E; Botta L; Sant M; Tavilla A; Minicozzi P AND The EUROCARE-5 Working Group, Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival of adults with primary malignant brain tumours in Europe. Results of the EUROCARE-5 study,  European Journal of Cancer 2015,51: 2231-2241.
  • Francisci S; Minicozzi P; Pierannunzio D; Ardanaz E; Eberle A; K. Grimsrud T; Knijn A; Pastorino U; Salmerón D; Trama A; Sant M; EUROCARE-5 Working Group(Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)).Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study, European Journal of Cancer 2015,51: 2242-2253.
  • De Angelis R; Minicozzi P; Sant M; Dal Maso L; H. Brewster D; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A AND the EUROCARE-5 Working Group (Marcos-Gragera R & Izquierdo Font A (Girona Cancer Registry)). Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study, European Journal of Cancer 2015,51: 2254-2268.
  • CANGIR: http://ico.gencat.cat/ca/professionals/serveis_i_programes/registre_del_cancer/
  • Anna Gavin; Brian Rous;  Rafael Marcos-Gragera; Richard Middleton; Eva Steliarova-Foucher; Marc Maynadie; Roberto Zanetti; Otto Visser. Towards optimal clinical and epidemiological registration of Haematological Malignancies: guidelines for recording progressions, transformations and multiple diagnoses. European Journal of Cancer (2014)
  • Domingo L, Salas D, Zubizarreta R, Baré M, Sarriugarte G, Barata T, Ibáñez J, Blanch J, Puig-Vives M, Fernández AB, Castells X, Sala M. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain. Breast Cancer Res. 2014 Jan 10;16(1):R3.
  • Ribes J, Esteban L, Clèries R, Galceran J, Marcos-Gragera R, Gispert R, Ameijide A, Vilardell ML, Borras J, Puigdefabregas A, Buxó M, Freitas A, Izquierdo A, Borras JM. Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models. Clin Transl Oncol. 2013 Dec 12.
  • Clèries R; Esteban L; Borràs J; Marcos-Gragera R; Freitas A; Carulla M; Buxó M; Puigdefàbregas A; Izquierdo A; Gispert R; Galceran J; Ribes J. Time trends of cancer incidence and mortality in Catalonia during 1993-2007. Clin Transl Oncol 2014 Jan;16(1):18-28.
  • Serdà Ferrer BC, Del Valle A, Marcos-Gragera R. Prostate Cancer and Quality of Life: Analysis of Response Shift Using Triangulation Between Methods. J Gerontol Nurs 2014; 40(6):32-41
  • Fuentes-Raspall R, Puig-Vives M, Guerra-Prio S, Perez-Bueno F, Marcos-Gragera R.Population-based survival of Central Nervous System Tumors (CNS) from 1994 to 2008. An up-dated assessment in the temozolomide-era. Cancer Epidemiology 2014; 38(3):244-7.
  • Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P,Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R; the EUROCARE Working Group. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Lancet Oncol 2014 Jan;15(1):35-47
  • Rubió-Casadevall J, Borràs JL, Carmona C, Ameijide A, Osca G, Vilardell L, Izquierdo A, Galceran J, Marcos-Gragera R. Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study. Clin Transl Oncol. 2013 Nov 19.
  • Puig-Vives M; Osca-Gelis G; Camprubí C; Vilardell L; Izquierdo A; Marcos-Gragera R. Proporción de cánceres de mama diagnosticados por el cribado poblacional, fuera de éste y cánceres de intervalo en la provincia de Girona. Med Clin (Barc). 2013 Dec 27.
  • Renart G, Saez M, Saurina C, Marcos-Gragera R, Ocaña-Riola R, Martos C, Barceló MA, Arribas F, Alcalá T. A common error in the ecological regression of cancer incidence on the deprivation index. Rev Panam Salud Publica. 2013 Aug;34(2):83-91.
  • M. Arnold; C. Holterhues; J.W. Coebergh; T. Nijsten; Eero Pukkala; Bernd Holleczek; Lafey Tryggvadóttir; Harry Comber; Maria José Bento; Chakameh Safaei Diba; Maja Primic Zakelj, M. Isabel Izarzugaza, Josefina Perucha González, Rafael Marcos-Gragera, Jaume Galceran, Eva Ardanaz Aicua, Robin Schaffar, Andy Pring, E. de Vries. The incidence of melanoma across Europe; predictions for 2010 up to 2015. Eur Acad Dermatol Venereol. 2013 Aug 21.
  • Osca-Gelis G, Puig-Vives M, Saez M, Gallardo D, Lloveras N, Marcos-Gragera R.Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain. Haematologica-The Hematology Journal 2013 2013 Aug;98(8):e95-7.
  • Montse Puig-Vives; MJ Sánchez; J Sánchez-Cantalejo; A Torrella-Ramos; C Martos; E Ardanaz; MD Chirlaque; J Perucha; JM Díaz; A Mateos; Machón M; Marcos-Gragera R. Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.  Gynecol Oncol. 2013 Sep;130(3):609-14.
  • Serda Bernat-Carles; Marcos-Gragera R. Urinary incontinence and prostate cancer: a progressive rehabilitation programme design.  Rehabil Nurs. 2013 Jun 18.
  • Crocetti E; Caldarella A; Ferretti S; Ardanaz E; Arveux P; Bara S; Barrios E; Bento M.J; Bordoni A; Buzzoni C; Candela G; Colombani F; Colonna M; Federico M; Francart J; Ganry O; Giacomin A; Grosclaude P; Guizard A-V; Izarzugaza I; Konzelmann I; La Rosa F; Ligier K; Mangone L; Marcos-Gragera R; Martinez R; Mercier M; Michelena M.J; Michiara M; Miranda A; Molinie F; Mugarza Gomez C; Paci E; Piffer S; Puig-Vives M; Sacchettini C; Sanchez M.J; Traina A; Tretarre B; Tumino R; Van Vaerenbergh E; Velten M; Vergnenegre A; Woronoff A.S. Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries. Breast. 2013 Aug;22(4):476-81.
  • Gatta G; Rossi S; Foschi R; Trama A; Marcos-Gragera R; Pastore G; Peris-Bonet R; Stiller C; Capocaccia R; Eurocare WG. Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. Haematologica-The Hematology Journal 2013May;98(5):744-52
  • Marc Maynadié; Roberta De Angelis; Rafael Marcos-Gragera; Otto Visser; Claudia Allemani; Carmen Tereanu; Riccardo Capocaccia; Adriano Giacomin; Jean-Michel Lutz; Carmen Martos; Risto Sankila; Tom Børge Johannesen; Arianna Simonetti; Milena Sant; the HAEMACARE Working Group. Survival of European patients diagnosed with myeloid malignancies in 2000-2002: a HAEMACARE study. Haematologica-The Hematology Journal 2013; 98(2):230-238
  • van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T; the RARECARE WG. Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project. Eur J Cancer 2013; Mar 27.
  • Pérez-García A, Osca G, Bosch-Vizcaya A, Kelleher N, Santos NY, Rodríguez R, González Y, Roncero JM, Coll R, Serrando M, Lloveras N, Tuset E, Gallardo D. Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription. Hum Immunol. 2013 Sep;74(9):1219-24.
  • Esteban L, Clèries R, Gálvez J, Pareja L, Escribà JM, Sanz X, Izquierdo A, Galcerán J, Ribes J. REGSTATTOOLS: freeware statistical tools for the analysis of disease population databases used in health and social studies. BMC Public Health. 2013 Mar 7;13:201. doi: 10.1186/1471-2458-13-201. PubMed PMID: 23497219;  PubMed Central PMCID: PMC3653818.
  • Rafael Marcos-Gragera. ¿Está aumentando el cáncer cutáneo en nuestro país? .  Piel. 2012;27:295-9 (EDITORIAL)
  • Salmerón D; Chirlaque MD; M Isabel Izarzugaza;  Sánchez MJ;  Marcos-Gragera R;  Ardanaz E;  Galceran J; Mateos A; Navarro C. Lung cancer prognosis in Spain: The role of histology, age and sex. Respir Med 2012;106(9):1301-8.
  • Gemma Osca-Gelis; Montserrat Puig-Vives; Marc Saez; David Gallardo; Francesc Solé; Rafael Marcos-Gragera. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a populationbased study, 1993-2007. Leuk Res  2012; 36(10):1262-6.  [IF: 2,555].
  • Puig Vives M; Pollan M; Rue M; Osca G; Saez M; Izquierdo A; Marcos-Gragera R. Rapid increase in detection rate of breast ductal carcinoma in situ in Girona, Spain 1983-2007. The Breast  2012; 21:646-651  [IF: 2,089]
  • Marcos-Gragera R; Salmerón D; Izarzugaza I; Ardanaz E;  Serda BC; Larrañaga N; San Roman E;  Navarro C;  Chirlaque MD.  Trends in prostate cancer survival in Spain: results from population-based cancer registries.  Clin Transl Oncol 2012;14(6):458-4.  [IF: 1,254]
  • Saez M; Barceló MA; Martos C; Saurina C; Marcos-Gragera R; Renart G; Ocaña-Riola R; Feja C; Alcalá T. Spatial variability in relative survival from female breast cancer. J R Statist Soc A 2012; 175:107-134  [IF: 2,57]
  • Clèries R; Ribes J; Buxo M; Ameijide A; Marcos-Gragera R; Galceran J; Martínez JM; Yasui Y. Bayesian approach to predicting cancer incidence for an area without cancer registration by using cancer incidence data from nearby areas. Stat Med 2012;31(10):978-87  
  • Alsina M; Marcos-Gragera R; Capdevila J; Buxó M; Ortiz RM; Barretina P; Vilardell L; Brunet J; Beltran M; Izquierdo Á. Neuroendocrine tumors: A population-based study of incidence and survival in Girona province, 1994-2004. Cancer Epidemiol 2011;35(6):e49-54  [IF: 1,18]   
  • Neus Vilar-Coromina, Josefina Miró-Queralt, Anabel Cano-Bautista, Loreto Vilardell-Gil, Rafael Marcos-Gragera. Cáncer de piel no melanoma: análisis de la tendencia de la incidencia poblacional, 1994-2007. Med Clin (Barc) 2011;137(4):145-51.  [IF: 1,41]
  • Marcos-Gragera R; Allemani C; Tereanu C; de Angelis R; Capocaccia R; Maynadie M; Luminari S; Ferretti S; Borge Johannesen T; Sankila R; Karjalainen-Lindsberg ML; Simonetti A; Martos C; Raphael M; Giraldo P; Sant M. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica  2011; 96(5):720-728 [IF: 6,53]
  • Castro Marqueta P; Judit Moreno-Crespi, Maria Buxó-Pujolràs, Marta Cervantes-Amat, Beatriz Pérez-Gómez ; Rafael Marcos-Gragera. Epidemiologia del cáncer de cérvix in situ e invasor en la província de Girona 1990-2004: incidencia, mortalidad, supervivencia e historial de cribado. Med Clin (Barc). 2011;136(5):192-198    [IF: 1,41]
  • Fuentes-Raspall R, Vilardell L, Perez-Bueno F, Joly C, Garcia-Gil M, Garcia-Velasco A, Marcos-Gragera R. Population-based incidence and survival of central nervous system (CNS) malignancies in Girona (Spain) 1994-2005. J Neurooncol 2011; 101(1):117-123 [IF: 2,929]
  • Neus Vilar-Coromina, Loreto Vilardell Gil, Annabel Cano Bautista, Rafael Marcos-Gragera. Rápido incremento de la incidencia del melanoma in situ en Girona (España), 1994-2005. Efectividad de la campañas de diagnóstico precoz?. Actas Dermosifiliogr. 2010;101(6):561-3. [no IF]
  • Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borras J, Cleries R, Ribes J, Gispert R, Izquierdo A, Borràs JM. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: Increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010 Sep 1;24(9):1083-8. [IF 2,787]
  • Marcos-Gragera R, Pollan M, Chirlaque MD, Guma J, Sanchez MJ, Garau I. Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain. Ann Oncol 2010 May;21 Suppl 3:iii90-iii96. [IF:5,647]
  • Marcos-Gragera, R., Cervantes-Amat, M., Vicente, M. L., de Sanjosé S; Guallar, E., Godoy, C., Calvo, C., Giraldo, P., Sant, M., Peris-Bonet, R., & Martos MC. Population-based incidence of childhood leukaemias and lymphomas in Spain (1993-2002). Eur J Cancer Prev. 2010 Jul;19(4):247-55. [IF: 2.205]
  • Carme Saurina, Marc Saez, Rafael Marcos-Gragera; Maria Antònia Barceló; Gemma Renart; Carmen Martos. Effects of the deprivation in the geographical variability of larynx cancer incidence in men, Girona (Spain) 1994-2004. Cancer Epidemiol 2010;34(2):109-15 [IF: 2.056]
  • Neus Vilar-Coromina, Ferran Pérez Bueno, Maria Alsina Maqueda, Loreto Vilardell Gil, Angel Izquierdo Font, Rafael Marcos-Gragera. Carcinoma de células de Merkel cutáneo primario: Incidencia y supervivencia poblacional, 1995-2005. Med Clin 2009;132(18): 701-3 [IF: 1.337]
  • Marcos-Gragera R, Cardó X, Galceran J, Ribes J, Izquierdo A, Borràs J.  Incidencia del cáncer en Cataluña, 1998-2002. Med Clin (Barc) 2008; 131(Suppl 1):4-10 [IF: 1.337]

Contacto

Dirección postal: Carrer del Sol num 15, 17004 Girona
Teléfono: 972 207406
Correo electrónico: rcgirona@iconcologia.net

Personas de contacto:

Rafael Marcos-Gragera: rmarcos@iconcologia.net

Ángel Izquierdo Font: aizquierdo@iconcologia.net


Web:http://www20.gencat.cat/portal/site/cancer

 

 

 

 

Desarrollado por Web4bio